COPENHAGEN, Denmark, Sept. 29, 2026 -- Breye Therapeutics ApS (Breye), a clinical-stage biopharmaceutical company developing oral therapeutics for the early treatment of retinal diseases, today announced the successful close of...

Pappas Capital, LLC
2520 Meridian Parkway
Suite 400
Durham, NC 27713
Mailing Address
P. O. Box 110287
Research Triangle Park, NC 27709
Tel: 919-998-3300
Fax: 919-998-3301